- Home
- BTAI vs PHUN Comparison
BTAI vs PHUN Comparison
Compare BTAI & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- PHUN
- Stock Information
- Founded
- BTAI 2017
- PHUN 2009
- Country
- BTAI United States
- PHUN United States
- Employees
- BTAI 37
- PHUN N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- BTAI Health Care
- PHUN Technology
- Exchange
- BTAI Nasdaq
- PHUN Nasdaq
- Market Cap
- BTAI 41.8M
- PHUN 55.9M
- IPO Year
- BTAI 2018
- PHUN N/A
- Fundamental
- Price
- BTAI $2.12
- PHUN $2.10
- Analyst Decision
- BTAI Buy
- PHUN Buy
- Analyst Count
- BTAI 5
- PHUN 2
- Target Price
- BTAI $32.80
- PHUN $7.25
- AVG Volume (30 Days)
- BTAI 691.3K
- PHUN 189.3K
- Earning Date
- BTAI 11-12-2025
- PHUN 11-06-2025
- Dividend Yield
- BTAI N/A
- PHUN N/A
- EPS Growth
- BTAI N/A
- PHUN N/A
- EPS
- BTAI N/A
- PHUN N/A
- Revenue
- BTAI $752,000.00
- PHUN $2,357,000.00
- Revenue This Year
- BTAI N/A
- PHUN N/A
- Revenue Next Year
- BTAI $544.99
- PHUN $72.40
- P/E Ratio
- BTAI N/A
- PHUN N/A
- Revenue Growth
- BTAI N/A
- PHUN N/A
- 52 Week Low
- BTAI $1.17
- PHUN $1.83
- 52 Week High
- BTAI $9.26
- PHUN $6.29
- Technical
- Relative Strength Index (RSI)
- BTAI 54.12
- PHUN 39.98
- Support Level
- BTAI $1.72
- PHUN $1.83
- Resistance Level
- BTAI $2.09
- PHUN $2.40
- Average True Range (ATR)
- BTAI 0.18
- PHUN 0.12
- MACD
- BTAI 0.06
- PHUN 0.00
- Stochastic Oscillator
- BTAI 98.36
- PHUN 47.37
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.